2YW-14779-54983
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 208 / MD
- Registered
- 2021-10-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-12
Registered in v-safe
-
2021-10-22
Dose 2 — Moderna
- 2021-11-01
- 2021-11-14
- 2021-11-19
- 2021-11-26
- 2021-12-03
-
2022-01-23
Survey response — 3 months, dose 2MedDRA: Influenza virus test negative, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: GoodFree text: Sore throat. Negative at home covid tests. Negative cvs covid / flu tests.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-22 | Moderna | No |
Free text
Release 11 — 3 months, dose 2
Symptoms: Sore throat. Negative at home covid tests. Negative cvs covid / flu tests.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release